Skip to campaign content
FIND DANKNational civic initiative

Find Dank · South Africa

National Cannabis Reform
& Patient Access Initiative

Every Voice Matters.
Every Experience Counts.
Let’s Build an Evidence-Based Future.

A nonpartisan space to document experiences, question assumptions and propose practical solutions. For patient access, public health, human rights, legal clarity and fair economic participation.

Preparation and review phase. Questionnaires are available to inspect; responses are not being collected until the required reviews are complete.

Clarity before conclusions

Different activities.
Different regulatory questions.

Private adult use, medical access, cultivation, commercial activity and regulated supply are not interchangeable. Private-use rights do not establish general permission to sell cannabis. Medical access engages medicines legislation and SAHPRA processes. Cultivation requirements depend on purpose and applicable law. Commercial supply requires its own lawful framework.

We will separate official facts from personal experiences, estimates, opinions and unverified allegations. Responses inform reviewed evidence; they do not establish clinical effectiveness, legal liability or national public opinion.

How your contribution is used

Authorised reviewers assess relevance, quality and privacy. Reviewed aggregate findings may inform reports and formal submissions. Raw responses are never placed on the public dashboard. Expert attribution requires separate permission and final review.

Participation does not guarantee regulatory change, access to treatment, a licence, employment or an official response.

Regulatory information

Source review: 2 November 2026. This is general information, not legal or medical advice. Current commencement notices, regulations and individual authorisation conditions must be checked before relying on any summary.

Unverified claim: we have not established authoritative documentation confirming an alleged November 2026 suspension of all Section 21 cannabis authorisations. No such blanket suspension is presented here as fact.

Read the public FAQ →